Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence.

MLA

Vanassche, T., et al. “Inhibition of Staphylothrombin by Dabigatran Reduces Staphylococcus Aureus Virulence.” Journal of Thrombosis and Haemostasis : JTH, vol. 9, no. 12, Dec. 2011, pp. 2436–46. EBSCOhost, https://doi.org/10.1111/j.1538-7836.2011.04529.x.

APA

Vanassche, T., Verhaegen, J., Peetermans, W. E., VAN Ryn, J., Cheng, A., Schneewind, O., Hoylaerts, M. F., & Verhamme, P. (2011). Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. Journal of Thrombosis and Haemostasis : JTH, 9(12), 2436–2446. https://doi.org/10.1111/j.1538-7836.2011.04529.x

Chicago

Vanassche, T, J Verhaegen, W E Peetermans, J VAN Ryn, A Cheng, O Schneewind, M F Hoylaerts, and P Verhamme. 2011. “Inhibition of Staphylothrombin by Dabigatran Reduces Staphylococcus Aureus Virulence.” Journal of Thrombosis and Haemostasis : JTH 9 (12): 2436–46. doi:10.1111/j.1538-7836.2011.04529.x.